Short Interest in IQVIA Holdings Inc. (NYSE:IQV) Rises By 27.5%

IQVIA Holdings Inc. (NYSE:IQV) was the recipient of a significant growth in short interest in the month of November. As of November 15th, there was short interest totalling 3,340,000 shares, a growth of 27.5% from the October 31st total of 2,620,000 shares. Based on an average daily volume of 1,470,000 shares, the days-to-cover ratio is currently 2.3 days. Approximately 1.9% of the shares of the company are short sold.

IQVIA Trading Up 0.5 %

Shares of NYSE:IQV traded up $0.95 on Monday, reaching $201.79. 1,867,915 shares of the company traded hands, compared to its average volume of 1,177,624. IQVIA has a 52 week low of $187.62 and a 52 week high of $261.73. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 1.76. The business’s 50-day simple moving average is $217.89 and its 200 day simple moving average is $225.88. The stock has a market capitalization of $36.62 billion, a P/E ratio of 26.48, a price-to-earnings-growth ratio of 2.07 and a beta of 1.51.

Hedge Funds Weigh In On IQVIA

Institutional investors and hedge funds have recently bought and sold shares of the stock. First Foundation Advisors boosted its holdings in shares of IQVIA by 3.8% during the second quarter. First Foundation Advisors now owns 1,161 shares of the medical research company’s stock worth $245,000 after purchasing an additional 43 shares during the period. Invera Wealth Advisors LLC raised its holdings in IQVIA by 0.3% in the 2nd quarter. Invera Wealth Advisors LLC now owns 14,506 shares of the medical research company’s stock worth $3,183,000 after purchasing an additional 46 shares in the last quarter. Private Trust Co. NA grew its holdings in shares of IQVIA by 10.7% during the 3rd quarter. Private Trust Co. NA now owns 485 shares of the medical research company’s stock worth $115,000 after acquiring an additional 47 shares during the period. Oregon Public Employees Retirement Fund boosted its position in shares of IQVIA by 0.3% during the second quarter. Oregon Public Employees Retirement Fund now owns 15,668 shares of the medical research company’s stock valued at $3,313,000 after purchasing an additional 48 shares in the last quarter. Finally, Continuum Advisory LLC grew its stake in IQVIA by 3.3% in the second quarter. Continuum Advisory LLC now owns 1,538 shares of the medical research company’s stock worth $325,000 after purchasing an additional 49 shares during the period. 89.62% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

IQV has been the topic of several research reports. TD Cowen lowered their price target on shares of IQVIA from $270.00 to $255.00 and set a “buy” rating on the stock in a research report on Friday, November 1st. Truist Financial cut their price target on IQVIA from $286.00 to $265.00 and set a “buy” rating for the company in a report on Monday, November 4th. Redburn Atlantic assumed coverage on IQVIA in a research note on Monday, October 14th. They set a “buy” rating and a $276.00 price objective on the stock. BTIG Research cut their target price on IQVIA from $290.00 to $260.00 and set a “buy” rating for the company in a research note on Friday, November 1st. Finally, Robert W. Baird decreased their price target on IQVIA from $256.00 to $223.00 and set a “neutral” rating on the stock in a research report on Friday, November 1st. Five research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $256.50.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.